Results and Publications

The soluble receptor for advanced glycation end products (sRAGE) can prospectively identify patients at greatest risk for preterm birth

Bastek JA, Brown AG, Foreman MN, McShea MA, Anglim LM, Adamczak JE, Elovitz MA.: The soluble receptor for advanced glycation end products (sRAGE) can prospectively identify patients at greatest risk for preterm birth. J Matern Fetal Neonatal Med February 2012.

U.S. National Library of Medicine abstract

Clinical Trials Now Recruiting!

Active Clinical Trials

Fertility and the BRCA gene

Non-hormonal intrauterine device

Research study for women with Heavy Menstrual Bleeding due to Uterine Fibroids

Infertility

IUD study for current Mirena users

Research Study for Overweight Women with PCOS (Polycystic Ovary Syndrome)